{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T15:49:41Z","timestamp":1759938581225,"version":"3.40.3"},"publisher-location":"Totowa, NJ","reference-count":20,"publisher":"Humana Press","isbn-type":[{"type":"print","value":"9781627031097"},{"type":"electronic","value":"9781627031103"}],"license":[{"start":{"date-parts":[[2012,9,24]],"date-time":"2012-09-24T00:00:00Z","timestamp":1348444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2012,9,24]],"date-time":"2012-09-24T00:00:00Z","timestamp":1348444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013]]},"DOI":"10.1007\/978-1-62703-110-3_20","type":"book-chapter","created":{"date-parts":[[2012,11,3]],"date-time":"2012-11-03T22:56:16Z","timestamp":1351983376000},"page":"239-267","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Methods for Monitoring Gene Gun-Induced HBV- and HCV-Specific Immune Responses in Mouse Models"],"prefix":"10.1007","author":[{"given":"Gustaf","family":"Ahl\u00e9n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matti","family":"S\u00e4llberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Frelin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,9,24]]},"reference":[{"key":"20_CR0201","doi-asserted-by":"publisher","first-page":"62S","DOI":"10.1002\/hep.510260711","volume":"26","author":"MJ Alter","year":"1997","unstructured":"Alter MJ (1997) Epidemiology of hepatitis C. Hepatology 26:62S\u201365S","journal-title":"Hepatology"},{"issue":"suppl 2","key":"20_CR0202","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1365-2893.1997.tb00177.x","volume":"4","author":"DR Milich","year":"1997","unstructured":"Milich DR (1997) Pathobiology of acute and chronic hepatitis B virus infection: an introduction. J Viral Hepat 4(suppl 2):25\u201330","journal-title":"J Viral Hepat"},{"key":"20_CR0203","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1053\/j.gastro.2009.08.063","volume":"137","author":"F Zoulim","year":"2009","unstructured":"Zoulim F, Locarnini S (2009) Hepatitis B virus resistance to nucleos(t)ide analogues. Gastroenterology 137:1593\u20131608","journal-title":"Gastroenterology"},{"key":"20_CR0204","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/S0140-6736(01)06102-5","volume":"358","author":"MP Manns","year":"2001","unstructured":"Manns MP et al (2001) Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 358:958\u2013965","journal-title":"Lancet"},{"key":"20_CR0205","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1056\/NEJMoa0806104","volume":"360","author":"JG McHutchison","year":"2009","unstructured":"McHutchison JG et al (2009) Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection. N Engl J Med 360:1827\u20131838","journal-title":"N Engl J Med"},{"key":"20_CR0206","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.4049\/jimmunol.145.10.3442","volume":"145","author":"C Ferrari","year":"1990","unstructured":"Ferrari C et al (1990) Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection. J Immunol 145:3442\u20133449","journal-title":"J Immunol"},{"key":"20_CR0207","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1038\/nature04079","volume":"436","author":"DG Bowen","year":"2005","unstructured":"Bowen DG, Walker CM (2005) Adaptive immune responses in acute and chronic hepatitis C virus infection. Nature 436:946\u2013952","journal-title":"Nature"},{"key":"20_CR0208","doi-asserted-by":"publisher","first-page":"9568","DOI":"10.1073\/pnas.87.24.9568","volume":"87","author":"NS Yang","year":"1990","unstructured":"Yang NS et al (1990) In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment. Proc Natl Acad Sci USA 87:9568\u20139572","journal-title":"Proc Natl Acad Sci U S A"},{"key":"20_CR0209","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/356152a0","volume":"356","author":"DC Tang","year":"1992","unstructured":"Tang DC, DeVit M, Johnston SA (1992) Genetic immunization is a simple method for eliciting an immune response. Nature 356:152\u2013154","journal-title":"Nature"},{"key":"20_CR02010","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/978-3-642-85208-4_9","volume":"206","author":"FV Chisari","year":"1996","unstructured":"Chisari FV (1996) Hepatitis B virus transgenic mice: models of viral immunobiology and pathogenesis. Curr Top Microbiol Immunol 206:149\u2013173","journal-title":"Curr Top Microbiol Immunol"},{"key":"20_CR02011","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1002\/hep.510250338","volume":"25","author":"C Pasquinelli","year":"1997","unstructured":"Pasquinelli C et al (1997) Hepatitis C virus core and E2 protein expression in transgenic mice. Hepatology 25:719\u2013727","journal-title":"Hepatology"},{"key":"20_CR02012","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1136\/gut.2005.085050","volume":"55","author":"L Frelin","year":"2006","unstructured":"Frelin L et al (2006) The hepatitis C virus and immune evasion: non-structural 3\/4A transgenic mice are resistant to lethal tumour necrosis factor alpha mediated liver disease. Gut 55:1475\u20131483","journal-title":"Gut"},{"key":"20_CR02013","doi-asserted-by":"publisher","first-page":"28343","DOI":"10.1074\/jbc.M109.038877","volume":"284","author":"M Kriegs","year":"2009","unstructured":"Kriegs M et al (2009) The hepatitis C virus non-structural NS5A protein impairs both the innate and adaptive hepatic immune response in vivo. J Biol Chem 284:28343\u201328351","journal-title":"J Biol Chem"},{"key":"20_CR02014","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1053\/gast.2002.31001","volume":"122","author":"H Lerat","year":"2002","unstructured":"Lerat H et al (2002) Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus. Gastroenterology 122:352\u2013365","journal-title":"Gastroenterology"},{"key":"20_CR02015","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1086\/498218","volume":"192","author":"G Ahlen","year":"2005","unstructured":"Ahlen G et al (2005) In vivo clearance of hepatitis C virus nonstructural 3\/4A-expressing hepatocytes by DNA vaccine-primed cytotoxic T lymphocytes. J Infect Dis 192:2112\u20132116","journal-title":"J Infect Dis"},{"key":"20_CR02016","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/sj.gt.3301933","volume":"10","author":"L Frelin","year":"2003","unstructured":"Frelin L et al (2003) Low dose and gene gun immunization with a hepatitis C virus nonstructural (NS) 3 DNA-based vaccine containing NS4A inhibit NS3\/4A-expressing tumors in vivo. Gene Ther 10:686\u2013699","journal-title":"Gene Ther"},{"key":"20_CR02017","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/sj.gt.3302184","volume":"11","author":"L Frelin","year":"2004","unstructured":"Frelin L et al (2004) Codon optimization and mRNA amplification effectively enhances the immunogenicity of the hepatitis C virus nonstructural 3\/4A gene. Gene Ther 11:522\u2013533","journal-title":"Gene Ther"},{"key":"20_CR02018","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1086\/652808","volume":"201","author":"J Nystrom","year":"2010","unstructured":"Nystrom J et al (2010) Improving on the ability of endogenous hepatitis B core antigen to prime cytotoxic T lymphocytes. J Infect Dis 201:1867\u20131879","journal-title":"J Infect Dis"},{"key":"20_CR02019","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/S0264-410X(00)00302-9","volume":"19","author":"MJ Roy","year":"2000","unstructured":"Roy MJ et al (2000) Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine. Vaccine 19:764\u2013778","journal-title":"Vaccine"},{"key":"20_CR02020","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1128\/JVI.01902-08","volume":"83","author":"L Frelin","year":"2009","unstructured":"Frelin L et al (2009) A mechanism to explain the selection of the hepatitis e antigen-negative mutant during chronic hepatitis B virus infection. J Virol 83:1379\u20131392","journal-title":"J Virol"}],"container-title":["Methods in Molecular Biology","Biolistic DNA Delivery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-62703-110-3_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T11:17:48Z","timestamp":1675768668000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-62703-110-3_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,24]]},"ISBN":["9781627031097","9781627031103"],"references-count":20,"URL":"https:\/\/doi.org\/10.1007\/978-1-62703-110-3_20","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2012,9,24]]},"assertion":[{"value":"24 September 2012","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}